Ligand Pharmaceuticals | LGND - Market Capitalization


Ligand Pharmaceuticals reported $3.53B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Enviri Corporation USD 1.45B 423M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Veracyte USD 3.33B 627M Dec/2025